Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
EpiPen Auto-Injectors May Get Stuck In Carrier Tube, FDA Warns November 5, 2018 Irvin Jackson Add Your Comments Problems with some EpiPen and EpiPen Jr. Auto-Injectors may cause the devices to jam, potentially delaying or preventing live-saving drugs during cases of anaphylactic shock, federal drug regulators and the manufacturers warn. On November 1, Mylan and it’s parent company, Pfizer, issued a Dear Healthcare Provider letter (PDF), warning about reports that some EpiPen and EpiPen Jr. Auto-Injectors, and their generic equivalents, jammed in their carrier tube. As part of its own warning about the EpiPen problems, the FDA indicated it is aware of the risk, but is unaware of any adverse event reports associated with the jammed auto-injectors. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The letter from Mylan indicates that in a small number of cases, the labels of the auto-injectors did not fully adhere to the surface, resulting in the device label becoming stuck inside its carrier tube. This can lead to the failure to administer the drug and a patient’s progression to a more severe allergic reaction. The letter indicates the problem affects some EpiPen 0.3 mg with NDC 49502-500-02 and the Authorized Generic with NDC 49502-102-02, both with expiration dates between June 2018 and February 2020. The problem can also affect EpiPen Jr. 0.15 mg with NDC 49502-501-02 and the Authorized Generic with NDC 49502-101-02, both with expiration dates between October 2018 and October 2019. Mylan’s letter gives detailed instructions on how to ensure the auto-injectors do not become jammed when needed. The letter claims the cause of the problem has been identified and preventative actions are in place to avoid similar problems in the future. The letter also indicates that the problem is only expected to affect about one auto-injector out of every 14,287. EpiPen Problems The letter comes about a year after a report about a growing number of EpiPen problems and failures was published by Bloomberg News, indicating that there had been at least 228 reports as of November 2017, with at least seven deaths and 35 hospitalizations associated with use of EpiPen products. The report was based on data obtained through the use of a Freedom of Information Act (FOIA) request, which Bloomberg News indicated shows a steady rise in the number of problems with EpiPens over the last five years. While there were just four reports of EpiPen failures in 2012, and 12 reports in 2013, the number jumped to 67 in 2014 and has continued to spike since then. The injector pens provide a critical treatment for individuals with severe allergies or asthma attacks. Many individuals carry an EpiPen at all times to inject epinephrine, a chemical that narrows blood vessels and opens the airways to the lungs, in the event they are having a serious or life-threatening allergy or asthma attack. The pens contain epinephrine, commonly referred to as adrenaline, a hormone that can reverse severe low blood pressure and increase the heart rate, muscle strength, blood pressure, and sugar metabolism. Treatment of epinephrine can also reverse wheezing, severe skin itching, hives and various other symptoms of an allergic reaction. In September 2017, the FDA sent a warning letter to Meridian Medical Technologies, which manufactures EpiPens that are distributed by Mylan. The letter indicated that FDA investigators discovered the manufacturer had failed to adequately investigate 171 sample pens sent back due to malfunctions between 2014 and 2017. The drug maker has been the subject of Congressional hearings, EpiPen lawsuits and public ridicule and derision since it sextupled the price of the epinephrine shots after purchasing the EpiPen brand in 2007. Critics claim that Mylan is price-gouging consumers by charging $600 for a pack of two EpiPens, which cost about $100 just 10 years ago. In August 2017, a number of EpiPen class action lawsuits were centralized for pretrial proceedings in the U.S. District Court for the District of Kansas as part of an MDL, or multidistrict litigation, under U.S. District Judge Daniel Crabtree. All of the lawsuits raise nearly identical allegations about anti-competitive conduct or unfair marketing practices associated with EpiPens. Most, if not all, of the complaints seek class action status to present claims for various groups of potential consumers who have used or need to use the injections, potentially impacting millions of Americans. Customers with questions about these latest EpiPen Auto-Injector jamming problems may contact Mylan Customer Relations at 1-800-796-9526. Adverse events and reactions can be reported to Mylan by calling 1-877-446-2679. The FDA also requests that any problems experienced also be reported to its MedWatch Adverse Event Reporting Program. Tags: Allergic Reaction, Anaphylaxis, EpiPen, Mylan, Pfizer More Lawsuit Stories Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial May 23, 2025 Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial May 23, 2025 Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs May 23, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (Posted: 2 days ago) After a growing body of evidence has linked use of the Depo-Provera birth control shot to an increased risk of brain tumors, thousands of women nationwide are seeking information on how to sign up for the Depo-Provera lawsuit. MORE ABOUT: DEPO-PROVERA LAWSUITCourt Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025) Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: 3 days ago) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025) Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: 4 days ago) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)
Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial May 23, 2025
Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial May 23, 2025
Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (Posted: 2 days ago) After a growing body of evidence has linked use of the Depo-Provera birth control shot to an increased risk of brain tumors, thousands of women nationwide are seeking information on how to sign up for the Depo-Provera lawsuit. MORE ABOUT: DEPO-PROVERA LAWSUITCourt Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)
Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: 3 days ago) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)
Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: 4 days ago) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)